Kristi E Gamarel1, Larry Brown2, Christopher W Kahler3, M Isabel Fernandez4, Douglas Bruce5, Sharon Nichols6. 1. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI USA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI USA. Electronic address: Kristi_Gamarel@brown.edu. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI USA; Department of Psychiatry, Rhode Island Hospital, Providence, RI USA. 3. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI USA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI USA. 4. Department of Preventive Medicine and Department of Public Health Program, College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL USA. 5. Department of Health Sciences, DePaul University, Chicago, IL USA. 6. Department of Neurosciences, University of California, San Diego, CA USA.
Abstract
OBJECTIVES: The purpose of this study was to better understand the prevalence and correlates of substance use behaviors among HIV-infected adolescents in HIV care settings. METHODS: A cross-sectional sample of 2216 youth living with HIV (YLWH; ages 12-26) were recruited through the Adolescent Trials Network for HIV Interventions. Participants completed a one-time survey on sociodemographic factors, substance use and health behaviors. We used logistic regression models to understand the correlates of substance use outcomes. RESULTS: Overall, weekly or more frequent tobacco use was reported by 32.9% of participants, 27.5% marijuana use, and 21.3% alcohol use; and 22.5% reported any other illicit drug use. In multivariable models, young MSM had higher odds of reporting each substance use behavior, and transgender women had increased odds of marijuana and other illicit drug use. Criminal justice involvement, unstable housing, condomless sex, and suboptimal antiretroviral therapy was associated with increased risk of substance use behaviors. CONCLUSIONS: Study findings highlight the need for regular screening for substance use in HIV care settings in order to improve access to and delivery of culturally competent substance use prevention and treatment services. Copyright Â
OBJECTIVES: The purpose of this study was to better understand the prevalence and correlates of substance use behaviors among HIV-infected adolescents in HIV care settings. METHODS: A cross-sectional sample of 2216 youth living with HIV (YLWH; ages 12-26) were recruited through the Adolescent Trials Network for HIV Interventions. Participants completed a one-time survey on sociodemographic factors, substance use and health behaviors. We used logistic regression models to understand the correlates of substance use outcomes. RESULTS: Overall, weekly or more frequent tobacco use was reported by 32.9% of participants, 27.5% marijuana use, and 21.3% alcohol use; and 22.5% reported any other illicit drug use. In multivariable models, young MSM had higher odds of reporting each substance use behavior, and transgender women had increased odds of marijuana and other illicit drug use. Criminal justice involvement, unstable housing, condomless sex, and suboptimal antiretroviral therapy was associated with increased risk of substance use behaviors. CONCLUSIONS: Study findings highlight the need for regular screening for substance use in HIV care settings in order to improve access to and delivery of culturally competent substance use prevention and treatment services. Copyright Â
Authors: M Isabel Fernández; Heather C Huszti; Patrick A Wilson; Shoshana Kahana; Sharon Nichols; René Gonin; Jiahong Xu; Bill G Kapogiannis Journal: AIDS Behav Date: 2015-05
Authors: Shoshana Y Kahana; Maria Isabel Fernandez; Patrick A Wilson; Jose A Bauermeister; Sonia Lee; Craig M Wilson; Lisa B Hightow-Weidman Journal: J Acquir Immune Defic Syndr Date: 2015-02-01 Impact factor: 3.731
Authors: Kristi E Gamarel; Sharon Nichols; Christopher W Kahler; Andrew O Westfall; Michelle A Lally; Craig M Wilson Journal: Sex Transm Infect Date: 2017-11-27 Impact factor: 3.519
Authors: Sheri L Towe; Christina S Meade; Christine C Cloak; Ryan P Bell; Julian Baptiste; Linda Chang Journal: J Neuroimmune Pharmacol Date: 2020-05-22 Impact factor: 4.147
Authors: Jared Lee; Ji-Young Lee; Christina S Meade; Michael Cohn; Antonio Chahine; Samantha E Dilworth; Jessica F Magidson; Hetta Gouse; Dietmar Fuchs; Adam W Carrico Journal: J Neurovirol Date: 2020-07-29 Impact factor: 2.643
Authors: Danita Jemison; Sequoia Jackson; Olorunleke Oni; Deva Cats-Baril; Shawdae Thomas-Smith; Abigail Batchelder; Allan Rodriguez; Samantha E Dilworth; Lisa R Metsch; Deborah Jones; Daniel J Feaster; Conall O'Cleirigh; Gail Ironson; Adam W Carrico Journal: AIDS Behav Date: 2019-09
Authors: Kristi E Gamarel; Kimberly M Nelson; Rob Stephenson; Olga J Santiago Rivera; Danielle Chiaramonte; Robin Lin Miller Journal: AIDS Behav Date: 2018-02